-
公开(公告)号:JPH05310744A
公开(公告)日:1993-11-22
申请号:JP11286392
申请日:1992-05-01
Applicant: KOWA CO
Inventor: KYOTANI YOSHINORI , TAIMA TSUTOMU , KURIHARA YUJI , KITAMURA TAKAHIRO , YAMAGUCHI TAKASHI , KAMIYA KAZUHIRO , ONOKI KAZUHIRO , SATO SEIICHI , OTA TOMIO , UCHIDA YASUYOSHI
IPC: A61K31/47 , A61K31/4741 , A61P9/04 , A61P9/06 , A61P9/08 , C07D491/052
Abstract: PURPOSE:To provide a new pyrano[2,3-f]quinoline derivative having excel lent antiarrhythmic action, cardiac action, vasodilative action, etc., and useful as a cardiac disease therapeutic agent represented by cardiac failures. CONSTITUTION:The compound of formula 1 (R is lower alkyl; R is H, halogen, OH, lower alkylsulfonyloxy, lower alkanoyloxy, lower alkoxy, azido, amino; R is H, lower alkyl; R is H, lower alkyl, OH, lower alkylamino, pyrrolidinyl or piperazinyl which may have a substituent; when a double bond exists between the 3,4 positions, the substituent R does not exist), e.g. 3acetoxy-6-methyl-3,4,7,8- tetrahydro-2H-pyrano[2,3-f]quinoline. The compound of formula 1-1 among the compounds of formula 1 is obtained by reacting a quinoline compound with an allyl halide compound, thermally subjecting the obtained compound of formula 3 to a Claisen rearrangement, reacting the reaction product with an aliphatic acid anhydride, reacting the obtained compound of formula 5 with a peracid, and subsequently treating the produced epoxy compound of formula 6 with an alkali halide.
-
公开(公告)号:JPH0150218B2
公开(公告)日:1989-10-27
申请号:JP20810581
申请日:1981-12-24
Applicant: KOWA CO
Inventor: SHIRATO SHOZO , ISHIHAMA HIROSHI , UCHIDA YASUYOSHI
IPC: A61K31/165 , A61P9/00 , C07C67/00 , C07C231/00 , C07C235/48 , C07C235/60 , C07D303/22
-
公开(公告)号:JPH01211567A
公开(公告)日:1989-08-24
申请号:JP3394988
申请日:1988-02-18
Applicant: KOWA CO
Inventor: TANABE SOHEI , SATO SEIICHI , KYOTANI YOSHINORI , OTA TOMIO , UCHIDA YASUYOSHI
IPC: C07D295/12 , A61K31/495 , A61P9/00 , C07D213/74 , C07D213/75 , C07D241/04 , C07D295/13
Abstract: NEW MATERIAL:A sulfonamide compound shown by the formula (R1 is lower alkyl, lower alkoxy or halogen; R2 is H, lower alkyl, aryl or arylalkyl; R3 is aryl or arylalkyl; R4 and R4' may be the same or different and H, lower alkyl or lower alkoxy; m is 0-3; n is 1-8) and an acid addition salt thereof. EXAMPLE:1-Diphenylmethyl-4-(3-benzenesulfonylaminopropyl)piperazine. USE:Useful as a drug for cardiovascular system. PREPARATION:For example, a compound shown by formula II is reacted with a compound shown by formula III in a solvent such as methylene chloride or chloroform at -10-+100 deg.C, preferably in the presence of a base such as sodium hydroxide to give a compound shown by formula I wherein R2 is H. Further this compound is reacted with a compound shown by the formula R2'Y (R2' is R2 except H; Y is halogen, alkylsulfonyloxy, etc.) and converted to a compound shown by formula I wherein R2 is except H.
-
公开(公告)号:JPS60226876A
公开(公告)日:1985-11-12
申请号:JP8322884
申请日:1984-04-25
Applicant: KOWA CO
Inventor: ISHIHAMA HIROSHI , OOTA TOMIO , SHIMIZU NOBORU , ISHIWATARI HIROYUKI , UCHIDA YASUYOSHI
IPC: C07D211/90 , A61K31/44 , A61K31/4427 , A61K31/455 , A61P7/02 , A61P9/00 , A61P9/08 , A61P9/10 , A61P9/12 , C07D211/00 , C07D213/00 , C07D233/00 , C07D401/12 , C07D401/14
Abstract: NEW MATERIAL:The compound of formula I [R1 and R2 are H, halogen, trihalomethyl or nitro; R3 is lower alkyl or group of formula II (B is 7-16C alkylene); A is C or N]. EXAMPLE:2,6-Demethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarbo xylic acid 3-methyl ester 5-[8-(1-imidarzolyl)octyl] ester. USE:A drug having vasodilating, blood flow increasing, thrombocyte coagulation inhibiting, and thromboxane-A2 formation inhibiting activities, and useful as a vasodilator, hypotensor, an antithrombotic agent, an antiarteriosclerotic agent, etc. The coronary blood flow can be increased and keeps the high level for a long period by the administration of the compound. PREPARATION:The compound of formula I can be prepared e.g. by reacting the compound of formula III (Y is active group) with imidazole or its alkali metal salt in an inert solvent at room temperature -80 deg.C for several -24hr while stirring.
-
公开(公告)号:JPS60208973A
公开(公告)日:1985-10-21
申请号:JP6217784
申请日:1984-03-31
Applicant: KOWA CO
Inventor: SHIRATO SHIYOUZOU , KAWAMURA KIYOSHI , AKASHI TOSHIHIRO , ISHIHAMA HIROSHI , UCHIDA YASUYOSHI
IPC: A61K31/35 , A61K31/352 , A61P9/08 , A61P9/12 , A61P25/02 , C07D303/16 , C07D311/64 , C07D407/12
Abstract: NEW MATERIAL:(2'R),(3R)-3,4-Dihydro-8-(2'-hydroxy-3'-isopropylamine)propoxy- 3-nitroxy-2H-1-benzopyran shown by the formula I or (2'S),(3R)-3,4-dihydro-80(2'- hydroxy-3'-isopropylamine)propoxy-3-nitroxy-2H-1-benzopyran shown by the formula II or its acid addition salt. USE:A remedy for diseases of circulatory system. Having vasodilating action, hypotensive action and beta-blocking action. PREPARATION:(3R)-3,4-Dihydro-3-nitroxy-2H-1-benzopyran-8-ol is reacted with (2R) of (2S) optical isomer of an epoxy compound shown by the formula III [A is (substituted) alkyl, aralkyl, or aryl] to give (2'R),(3R)- or (2'R),(3R)-3,4-dihydro-8- (2',3'-epoxy)propoxy-3-nitroxy-2H-1-benzopyran, which is reacted with isopropylamine to give a compound shown by the formula I or formula II.
-
公开(公告)号:JPS6025958A
公开(公告)日:1985-02-08
申请号:JP13184583
申请日:1983-07-21
Applicant: KOWA CO
Inventor: UCHIDA YASUYOSHI , SHIGIYOU HIROMICHI , SATOU SEIICHI , SHIBUYA MASAYUKI , OOTA TOMIO , ISHIHAMA HIROSHI
IPC: C07D295/14 , C07C45/67 , C07C67/00 , C07C203/04 , C07C205/32 , C07C213/00 , C07C217/14 , C07C217/18 , C07C231/02 , C07C233/25 , C07C233/33 , C07C233/36 , C07C235/04 , C07C237/04 , C07C237/42 , C07D213/80 , C07D213/81 , C07D295/092 , C07D295/15
Abstract: NEW MATERIAL:The compound of formula I (R1 is H, lower alkyl, lower alkoxy, etc.; R2 is H or lower alkyl; R3 is nitroxy, trifluoromethyl or F; R4 and R5 are H, lower alkyl, halogen-substituted benzoyl, etc.; A is single bond, O imino, residue of -CONH-, etc.; B is O or residue of -NHCO-; X1 and X2 are aklylene). EXAMPLE:2-Dimethylamino-2'-methoxy-5'-(2-nitroxyethoxy)-acetanilide. USE:Useful as a drug for the circulatory system, e.g. hypotensor, anti-stenocardia, antiarrhythmic agent, etc. PREPARATION:The objective compound of e.g. formula II is produced by using a substituted aniline or a substituted phenol as a starting substance, and reacting e.g. a substituted aniline with a halogeno-aliphatic carboxylic acid or N-protected amino-apliphatic carboxylic acid and its reactive derivative.
-
公开(公告)号:JPH0422887B2
公开(公告)日:1992-04-20
申请号:JP6217784
申请日:1984-03-31
Applicant: KOWA CO
Inventor: SHIRATO SHOZO , KAWAMURA KYOSHI , AKASHI TOSHIHIRO , ISHIHAMA HIROSHI , UCHIDA YASUYOSHI
IPC: A61K31/35 , A61K31/352 , A61P9/08 , A61P9/12 , A61P25/02 , C07D303/16 , C07D311/64 , C07D407/12
-
公开(公告)号:JPH02255614A
公开(公告)日:1990-10-16
申请号:JP7497089
申请日:1989-03-29
Applicant: KOWA CO
Inventor: UCHIDA YASUYOSHI
IPC: C07D311/64 , A61K31/35 , A61K31/352 , A61K31/353 , A61P9/08 , A61P9/10
Abstract: PURPOSE:To obtain a preventive agent against twitch complicated with laser arterioplasty containing nipradilol as an active ingredient. CONSTITUTION:The objective substance obtained by containing nipradilol, one of racemic modifications thereof, one of optical isomers or a mixture thereof, preferably (2'R).(3R)-nipradilol as an active ingredient, suitably blending the active ingredient with normally used pharmaceutical raw materials and preparing a pharmaceutical according to a conventional method. The preventive agent is preferably intravenously administered; however, the agent can be prepared into a dosage form for oral or rectal administration. The agent is administered in an amount of 0.001-100mg, preferably 0.1-10mg expressed in terms of the nipradilol 5min to 1hr before cautery. The nipradilol is a compounded of a chemical name 3,4-dihydro-8-(2'-hydroxy-3'-isopropylamino)propoxy-3-nitroxy-2H-1- benzopyran.
-
公开(公告)号:JPS60181083A
公开(公告)日:1985-09-14
申请号:JP3617884
申请日:1984-02-29
Applicant: KOWA CO
Inventor: SHIRATO SHIYOUZOU , KAWAMURA KIYOSHI , AKASHI TOSHIHIRO , ISHIHAMA HIROSHI , UCHIDA YASUYOSHI
IPC: A61K31/35 , C07D311/64
Abstract: NEW MATERIAL:The racemic compound (351-A) consisting of 3,4-dihydro-8-(2- hydroxy-3-isopropylamino)propoxy-3-nitroxy-2H-1-benzopyran (2S), (3S) and (2R), (3R), and the racemic compound (351-B) consisting of (2R), (3S) and (2S), (3R). USE:A beta-blocker and vasodilator. PREPARATION:One of the above racemic compounds is made to react with the compound of formula I [R is (cyclo)alkyl, aryl or aralkyl] or its reactive derivative to obtain the compound of formula II, which is converted to the oxazolinium ion of formula III with a conversion reagent (e.g. thionyl chloride). The ion is treated with an acid and hydrolyzed to obtain the other racemic compound.
-
公开(公告)号:JP2577222B2
公开(公告)日:1997-01-29
申请号:JP8702187
申请日:1987-04-10
Applicant: KOWA CO
Inventor: SHIBUYA MASAYUKI , TAKAHASHI YOSHIO , SATO SEIICHI , SHIGYO HIROMICHI , OOTA TOMIO , UCHIDA YASUYOSHI
IPC: C07D233/61 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/4418 , A61P9/06 , C07D213/04 , C07D213/30 , C07D213/40 , C07D213/50 , C07D213/70 , C07D213/79 , C07D213/80 , C07D213/82 , C07D213/89 , C07D233/54 , C07D233/64 , C07D233/84 , C07D471/04 , C07D521/00
-
-
-
-
-
-
-
-
-